Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
Clinical trial NCT06375005 · RECRUITING
Trial details
- NCT number
- NCT06375005
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-06
- Primary completion
- 2027-01-06
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.